-
Mashup Score: 1Pre-pandemic ED visits for alcohol-related hepatitis rose by 4.4% among younger patients - 2 month(s) ago
An analysis of ED utilization from 2016 to 2019 revealed an increase in visits for alcohol-associated hepatitis, particularly among patients aged 25 to 44 years, as well as an increase in disease severity. “Alcohol-associated hepatitis (AH) is the most severe form of liver disease on the spectrum of alcohol-associated liver disease (ALD) with high short- and long-term mortality and
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 0
Results highlight the benefit of achieving sustained virological response with DAAs for decreasing patients’ risk of carotid atherosclerosis and peripheral artery disease, especially among those with severe fibrosis.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 20A 68-Year-Old Woman With Unexplained Liver Enzyme Elevation and Active Chronic Hepatitis: Beware of Drug-Induced Autoimmune-Like Hepatitis - 3 month(s) ago
This patient’s case history (void of protected health information) was discussed in a multidisciplinary meeting including hepatologists (LD, MG), a pathologist (DK), an immunologist (EP) with NC as moderator. We summarize the case history and discussion in the following article.
Source: www.gastrojournal.orgCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 0Investigational HCV Therapy Demonstrates 98% Sustained Virologic Response at Week 4 - 3 month(s) ago
Atea Pharmaceuticals announced topline data from their phase 2 trial showing a higher than expected efficacy for the study.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 4A Model to Eliminate Viral Hepatitis Infection in Migrants: A Prospective, Multicenter Study in Southern Italy - 4 month(s) ago
Data on the prevalence of hepatitis C virus (HCV) and hepatitis B virus (HBV) in migrants living in Italy are scanty,1 and there are few screening and linkage-to-care programs for this target.
Source: www.gastrojournal.orgCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 0Hepatitis C: The Year in Review - 4 month(s) ago
In 2023, there were numerous developments in hepatitis C including the Biden Administration’s new budget that put aside several billion dollars towards establishing a hepatitis C (HCV) program; GSK’s investigational hepatitis therapy began phase 3 trials; and the Cherokee Nation’s Hepatitis C elimination program which has worked to increase screening and get people into the continuum of care. Check out these stories and more from this year.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 0
According to a recent study, DAAs remain underutilized in patients with HCV-related HCC, despite improved survival outcomes.
Source: www.docwirenews.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 0
Just 8.5% of eligible patients were screened for hepatitis C, and among them, 5.9% tested positive for HCV antibody and 3.0% had an active infection.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 7Moving from Hepatitis Discovery to Elimination - 5 month(s) ago
To facilitate discussions around research and implementation strategies to advance the goal of hepatitis elimination, NIH staff (including DCB) and the Coalition for Global Hepatitis Elimination launched a webinar series, “Moving from Hepatitis Discovery to Elimination: NIH Research Advancing Hepatitis Elimination.”
Source: www.cancer.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Improving Hepatitis C Care Through Point-of-Diagnostic Treatment - 5 month(s) ago
High cure rates underscore the effectiveness of the No One Waits (NOW) model in ensuring not only treatment initiation but also successful completion, ultimately reducing the burden of HCV in the studied population and possibly beyond.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet
An analysis of ED utilization from 2️⃣0️⃣1️⃣6️⃣ to 2️⃣0️⃣1️⃣9️⃣ revealed an increase in visits for alcohol-associated #hepatitis, particularly among patients aged 25 to 44 years, as well as an increase in disease severity. Learn more at the 🔗 below 👇🏼 https://t.co/yxwsBQ0DmG